1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC

• Sonal Singh,
• Kristian Thorlund,
• Aranka Anema,
• Suad Kabbaha,
• Sarah Dempsey

Affiliations

Sonal Singh

assistant professor of medicine

Kristian Thorlund

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada, McMaster University, Hamilton, Ontario, Canada

Aranka Anema

PhD student

Suad Kabbaha

1BioSpark AI Technologies Inc., Vancouver, BC, Canada

Sarah Dempsey

1BioSpark AI Technologies Inc., Vancouver, BC, Canada